Notwithstanding these observations, it remains unclear whether TNF-α blockers unmask pre-existing MS, provoke de novo demyelinating disease, or whether these observations are a result of a greater predisposition or developing another IMID. The gene discussed is TNF; the disease is myeloid sarcoma.